RJT
CRL icon

Raymond James Trust’s Charles River Laboratories CRL Stock Holding History

Raymond James Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$211K Buy
+1,072
New +$223K ﹤0.01% 1227
2024
Q2 		– Sell
-1,001
Closed -$271K – 1267
2024
Q1 		$271K Sell
1,001
-113
-10% -$27K 0.01% 1031
2023
Q4 		$263K Buy
1,114
+17
+2% +$3.34K 0.01% 995
2023
Q3 		$215K Sell
1,097
-20
-2% -$4.11K 0.01% 1046
2023
Q2 		$235K Buy
1,117
+51
+5% +$10.1K 0.01% 1027
2023
Q1 		$216K Sell
1,066
-23
-2% -$5.21K 0.01% 1032
2022
Q4 		$237K Sell
1,089
-138
-11% -$30.1K 0.01% 964
2022
Q3 		$241K Sell
1,227
-255
-17% -$55K 0.01% 896
2022
Q2 		$318K Sell
1,482
-43
-3% -$10.5K 0.01% 778
2022
Q1 		$433K Buy
1,525
+384
+34% +$118K 0.01% 695
2021
Q4 		$430K Buy
1,141
+376
+49% +$146K 0.01% 716
2021
Q3 		$315K Sell
765
-58
-7% -$24.1K 0.01% 831
2021
Q2 		$304K Sell
823
-344
-29% -$115K 0.01% 850
2021
Q1 		$338K Buy
1,167
+108
+10% +$30K 0.01% 772
2020
Q4 		$265K Buy
1,059
+54
+5% +$12.9K 0.01% 825
2020
Q3 		$228K Sell
1,005
-383
-28% -$79.5K 0.01% 824
2020
Q2 		$242K Buy
+1,388
New +$222K 0.01% 758

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Raymond James Trust's CRL Position: Q3 2024 in Review

Raymond James Trust opened a new position in Charles River Laboratories (CRL) in Q3 2024: 1,072 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #1227 among its holdings. This is a return to the name: Raymond James Trust previously reported a position in CRL as recently as Q1 2024.

Raymond James Trust first reported a position in CRL in Q2 2020 and has held it in 17 quarters since. The position peaked at $433K in Q1 2022. 627 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • Raymond James Trust held 1,072 shares of Charles River Laboratories worth $211K as of Q3 2024.
  • Charles River Laboratories was a new Raymond James Trust position in Q3 2024.
  • Charles River Laboratories made up ﹤0.01% of Raymond James Trust's portfolio in Q3 2024, its #1227 holding.
  • Raymond James Trust first reported a position in Charles River Laboratories in Q2 2020 and has held it in 17 quarters since.
  • Raymond James Trust's Charles River Laboratories position peaked at $433K in Q1 2022.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.